Irinotecan Accord 300 mg/15 ml Concentrato per soluzione per Infusione

Country: Switzerland

Language: Italian

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Active ingredient:

irinotecani hydrochloridum trihydricum

Available from:

Accord Healthcare AG

ATC code:

L01CE02

INN (International Name):

irinotecani hydrochloridum trihydricum

Pharmaceutical form:

Concentrato per soluzione per Infusione

Composition:

irinotecani hydrochloridum trihydricum 300 mg, acidum lacticum, sorbitolum 675 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium max. 1.21 mg.

Class:

A

Therapeutic group:

Synthetika

Therapeutic area:

Farmaco

Authorization status:

zugelassen

Authorization date:

2018-09-24